Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross I Baker

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
The Medical Journal of Australia|April 30, 2004
Prevention of recurrent thrombosis in the antiphospholipid antibody syndrome: how long and how high with oral anticoagulant therapy?Ross I Baker
ANZ Journal of Surgery|May 16, 2007
Routine prevention of venous thromboembolism after surgery: the time for actionRoss I Baker
Journal of Clinical Medicine|March 17, 2025
Management of Bleeding, Thrombotic and Pregnancy-Related Complications in Women with Myeloproliferative Neoplasms: A Case-Based Review Focusing on Sex-Specific ChallengesThita Chiasakul, Ross I Baker
Hamostaseologie|February 22, 2023
Low von Willebrand Disease: A Bleeding Disorder of Unknown Cause?James S O'Donnell, Ross I Baker
Blood|August 16, 2021
How I treat bleeding disorder of unknown causeRoss I Baker, James S O'Donnell
The Medical Journal of Australia|April 19, 2012
Avoiding adverse events with dabigatran by careful selection of eligible patientsRoss I Baker, Paul Harper, Claire McLintock
Journal of Thrombosis and Haemostasis : JTH|September 12, 2024
Low von Willebrand factor-unraveling an enigma wrapped in a conundrumJames S O'Donnell, Ross I Baker, Ferdows Atiq
The Medical Journal of Australia|February 14, 2002
HaematologyRoss I Baker, Alison M Street, Kerry M Taylor
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 2003
Venous thromboembolism in travellers: can we identify those at risk?Andrew D McQuillan, John W Eikelboom, Ross I Baker
Cancers|December 11, 2022
Adenosine 2A Receptor Activation Amplifies Ibrutinib Antiplatelet Effect; Implications in Chronic Lymphocytic LeukemiaOmar Elaskalani, Grace Gilmore, Madison Hagger, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
The Medical Journal of Australia|April 30, 2004
Prevention of recurrent thrombosis in the antiphospholipid antibody syndrome: how long and how high with oral anticoagulant therapy?Ross I Baker
ANZ Journal of Surgery|May 16, 2007
Routine prevention of venous thromboembolism after surgery: the time for actionRoss I Baker
Journal of Clinical Medicine|March 17, 2025
Management of Bleeding, Thrombotic and Pregnancy-Related Complications in Women with Myeloproliferative Neoplasms: A Case-Based Review Focusing on Sex-Specific ChallengesThita Chiasakul, Ross I Baker
Hamostaseologie|February 22, 2023
Low von Willebrand Disease: A Bleeding Disorder of Unknown Cause?James S O'Donnell, Ross I Baker
Blood|August 16, 2021
How I treat bleeding disorder of unknown causeRoss I Baker, James S O'Donnell
The Medical Journal of Australia|April 19, 2012
Avoiding adverse events with dabigatran by careful selection of eligible patientsRoss I Baker, Paul Harper, Claire McLintock
Journal of Thrombosis and Haemostasis : JTH|September 12, 2024
Low von Willebrand factor-unraveling an enigma wrapped in a conundrumJames S O'Donnell, Ross I Baker, Ferdows Atiq
The Medical Journal of Australia|February 14, 2002
HaematologyRoss I Baker, Alison M Street, Kerry M Taylor
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 2003
Venous thromboembolism in travellers: can we identify those at risk?Andrew D McQuillan, John W Eikelboom, Ross I Baker
Cancers|December 11, 2022
Adenosine 2A Receptor Activation Amplifies Ibrutinib Antiplatelet Effect; Implications in Chronic Lymphocytic LeukemiaOmar Elaskalani, Grace Gilmore, Madison Hagger, et al.
Pageof 6